Skip to main content Start main content

News

Picture1

RCOcean Shines at Brazilian International Symposium, Showcasing Cutting-Edge Research in Marine Natural Products

Leading the Dialogue: Marine Drug Discovery at the Forefront On May 23, 2025, the Symposium on Traditional and Marine Natural Products, hosted by Universidade Federal de São Paulo (UNIFESP) in Santos, gathered leading scientists in the field of natural product research. PolyU-BGI Joint Research Centre for Genomics and Synthetic Biology in Global Ocean Resources (RCOcean) was invited as a key international partner to present its latest innovations at the intersection of genomics, artificial intelligence, and marine drug discovery. The event marked a new step forward in China-Brazil scientific collaboration in the field of natural products. The symposium was opened by renowned scholar Prof. Norberto Peporine Lopes from the University of São Paulo. In his address, he emphasized that “the diversity of natural products is a treasure trove for drug development, and interdisciplinary collaboration—including molecular biology, genomics, and artificial intelligence—is the driving force to unlock its full potential.” The RCOcean team presented three key reports at the event: Prof. Simon Ming-Yuen, LEE, Director of RCOcean, delivered a talk titled “Discovery of Natural Products from Medicinal Plants and Marine Organisms for Neurodegenerative Disease Treatment”. He introduced the team’s recent progress in identifying marine bioactive compounds through genomics approaches, highlighting their therapeutic potential for conditions such as Alzheimer’s and Parkinson’s diseases. Mr Jianwei Chen, Associate Director of RCOcean, presented “Systematic Mining of Bioactive Natural Peptides from the Microbiomes Using Machine Learning”. He outlined the development of an AI-driven platform for high-efficiency screening of marine microbial peptides, emphasizing their promise as candidates for novel antibiotics and anti-stroke therapeutics. PhD student Ling Peng presented findings from her research titled “Deciphering the Fungal Diversity and Genomic Functionality of Mangrove Rhizosphere Soil in China”, shedding light on the pharmaceutical and biotechnological potential of fungal resources in these unique habitats. Brazilian Scientists Highlight Local Breakthroughs: The symposium also featured leading Brazilian researchers. Prof. Paula C. Jimenez (UNIFESP) shared her team’s bioprospecting efforts on anti-cancer agents from coastal microorganisms and invertebrates. Prof. João Henrique Ghilardi Lago (UFABC) discussed the Bioactive Secondary Metabolites in Antiparasitic, Antitumor, and Antimicrobial Models. Prof. Leticia Veras Costa Lotufo (USP) introduced novel Connecting Dots— What Can We Learn About Cancer Biology from the Understanding of Natural Products Mechanism of Action. A Visit to Center for Marine Biology: Charting New Frontiers for Blue Economy Cooperation On May 24, the RCOcean delegation visited the Center for Marine Biology (CEBIMar) of the University of São Paulo, one of South America's leading platforms for marine ecosystem research. Prof. Ronaldo Bastos Francini Filho, director of CEBIMar, showcased deep-sea live organism cultivation technologies, enabling the long-term laboratory survival of rare marine species. Dr. Hudson Tercio Pinheiro presented integrated research combining genomics and biogeography to unravel the evolutionary patterns of mesophotic coral reefs. The center’s extensive specimen repository of rare tropical marine organisms offers unique resources for future pharmaceutical development. Prof. Simon Ming-Yuen, LEE and the CEBIMar team explored three major avenues for collaboration: Smart Diving Equipment Development – Combining advanced manufacturing in the Greater Bay Area with Brazil’s deep-sea exploration expertise. Genomic Profiling of Live Marine Samples – Building a fast-track, trans-hemispheric bio-sample identification platform. Synthetic Biology Technology Transfer – Jointly developing pharmaceutical pipelines from Brazil’s endemic marine microbes. “Sustainable exploration of ocean resources requires global collaboration,” said Prof. LEE. “Leveraging Hong Kong’s position as an international innovation hub, RCOcean looks forward to working closely with Brazilian partners to chart a scientific path for the blue economy.”

3 Jul, 2025

3

RCOcean research project wins funding support from RAISe+ Scheme

The Innovation and Technology Commission of the HKSAR Government has recently announced the second batch of projects selected for funding under the Research, Academic, and Industry Sectors One-plus (RAISe+) Scheme. Prof. Simon Ming-yuen LEE, the director of the PolyU-BGI Joint Research Centre for Genomics and Synthetic Biology in Global Ocean Resources, has been awarded funding support from the RAISe+ Scheme for his project “Novel Nutraceuticals for Neurodegenerative Diseases”. This project develops novel nutraceuticals and drugs derived from natural resources for treating neurodegenerative diseases. It establishes the LifeChip technology platform, combining next-generation DNA sequencing, AI-driven discovery, advanced chemical separation, high-throughput in vivo screening, and synthetic biology. Focusing on neurodegenerative diseases like Alzheimer’s and Parkinson’s, as well as neurological disorders including insomnia, depression, and anxiety, this integrated approach delivers a comprehensive solution for both prevention and treatment using innovative nutraceuticals with unique mechanisms of action. For instance, the development candidate Oxyphylla® is a first-in-class drug targeting α-synuclein, an emerging therapeutic target for Parkinson’s disease. Oxyphylla® is anticipated to become a disease-modifying therapy, offering a breakthrough in neurological health. Inaugurated in 2023, the RAISe+ Scheme aims to provide funding, on a matching basis, for at least 100 research teams from universities funded by the University Grants Committee which demonstrate strong potential to evolve into successful startups. Each approved project will receive funding support ranging from HK$10 million to HK$100 million.

20 Jun, 2025

Image_20250417115330

Driving Scientific Innovation and Publication Excellence with the European Journal of Pharmacology and Elsevier

PolyU-BGI Joint Research Centre for Genomics and Synthetic Biology in Global Ocean Resources (RCOcean) is proud to organize an insightful forum titled "Driving Scientific Innovation and Publication Excellence with the European Journal of Pharmacology and Elsevier" on 15 April. This event gathered top experts and scholars to discuss cutting-edge developments in pharmacology and scientific publishing. The forum will feature a keynote presentation by Prof. Frank Redegeld from the Faculty of Science at Utrecht University. Prof. Redegeld will delve into the topic of "Eosinophilic Esophagitis – An Emerging Disease: Novel Insights into the Local Immunological Events in Eosinophilic Esophagitis." His talk will explore the latest research findings on this increasingly recognized condition, highlighting the complex immunological processes involved and potential implications for treatment and management. In addition, Dr. Xu Liu, a distinguished publisher for the European Journal of Pharmacology, Life Sciences, and Fitoterapia, will present on "Generative Artificial Intelligence (GenAI) in Scientific Writing and Scholarly Publishing." Dr. Liu will discuss the transformative impact of GenAI technologies on the landscape of scientific communication, offering insights into how these tools can enhance the quality and efficiency of scholarly writing and publication processes. This forum represents a unique opportunity for researchers, academics, and industry professionals to engage with pioneering ideas and foster collaborations that drive scientific innovation. Attendees will gain valuable knowledge on emerging trends and technologies that are shaping the future of pharmacology and scientific publishing.

13 Apr, 2025

News Item

14 Mar, 2025

Your browser is not the latest version. If you continue to browse our website, Some pages may not function properly.

You are recommended to upgrade to a newer version or switch to a different browser. A list of the web browsers that we support can be found here